Cargando…
Use of a panel of four microRNAs in CSF as a predicted biomarker for postoperative neoangiogenesis in moyamoya disease
INTRODUCTION AND AIMS: At present, the treatment for moyamoya disease (MMD) primarily consists of combined direct and indirect bypass surgery. Nevertheless, more than half of indirect bypass surgeries fail to develop good collaterals from the dura and temporal muscle. This study aimed to investigate...
Autores principales: | Wang, Gang, Wen, Yunyu, Chen, Siyuan, Zhang, Guozhong, Li, Mingzhou, Zhang, Shichao, Qi, Songtao, Feng, Wenfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265944/ https://www.ncbi.nlm.nih.gov/pubmed/33942536 http://dx.doi.org/10.1111/cns.13646 |
Ejemplares similares
-
A Panel of Exosome-Derived miRNAs of Cerebrospinal Fluid for the Diagnosis of Moyamoya Disease
por: Wang, Gang, et al.
Publicado: (2020) -
Ultrasonic hemodynamic changes of superficial temporal artery graft in different angiogenesis outcomes of Moyamoya disease patients treated with combined revascularization surgery
por: Chen, Siyuan, et al.
Publicado: (2023) -
A Hybrid Strategy for Patients With Complex Cerebral Aneurysm: STA–MCA Bypass in Combination With Endovascular Embolization
por: Wang, Gang, et al.
Publicado: (2021) -
Is STA really a low‐flow graft? A quantitative ultrasonographic study of the flow of STA for cerebral revascularization in MMD patients
por: Wen, Yunyu, et al.
Publicado: (2023) -
Recognition of the Effect of Indirect Revascularization for Moyamoya Disease: The Balance Between the Stage Progression and Neoangiogenesis
por: Bao, Xiang-Yang, et al.
Publicado: (2022)